SERODUS AS has a total of 14 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Australia and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are OPTIKIRA LLC, YING JUN and S C R NEWPHARM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | United Kingdom | 2 | |
#4 | Canada | 1 | |
#5 | Hong Kong | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Levy Finn Olav | 11 |
#2 | Klaveness Jo | 8 |
#3 | Brudeli Bjarne | 4 |
#4 | Brudeli Bjame | 4 |
#5 | Moltzau Lise Roman | 4 |
#6 | Gulbrandsen Trygve | 4 |
#7 | Larsen Bjarne Due | 1 |
#8 | Kapusta Daniel R | 1 |
#9 | Petersen Jorgen Soberg | 1 |
#10 | Harlow Kenneth William | 1 |
Publication | Filing date | Title |
---|---|---|
GB0905641D0 | Compounds | |
GB0804320D0 | Treatment of heart failure | |
AU2004303722A1 | Modulators of peripheral 5-HT receptors |